LENZ Therapeutics Stock (NASDAQ: LENZ) stock price, news, charts, stock research, profile.
Open | $21.60 |
Close | $21.81 |
Volume / Avg. | 116.03K / 206.26K |
Day Range | 20.86 - 22.15 |
52 Wk Range | 14.42 - 24.59 |
Market Cap | $556.91M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 74 |
Short Interest | - |
Days to Cover | 4.32 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of LENZ Therapeutics (NASDAQ:LENZ) through any online brokerage.
Other companies in LENZ Therapeutics’s space includes: Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Korro Bio (NASDAQ:KRRO), PepGen (NASDAQ:PEPG) and Altimmune (NASDAQ:ALT).
There is no analysis for LENZ Therapeutics.
LENZ Therapeutics has a consensus price target of $31.33.
The stock price for LENZ Therapeutics (NASDAQ: LENZ) is $21.81 last updated July 17, 2024 at 4:00 PM EDT.
There are no upcoming dividends for LENZ Therapeutics.
LENZ Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for LENZ Therapeutics.
LENZ Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.